Mr Tom Robertshaw

James, E., Keppler, J., Robertshaw, T. L. and Sessa, B. 2022. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Human Psychopharmacology: Clinical and Experimental 37(3), article number: e2835. (10.1002/hup.2835)

James, E., Robertshaw, T. L., Hoskins, M. and Sessa, B. 2020. Psilocybin occasioned mystical‐type experiences. Human Psychopharmacology: Clinical and Experimental 35(5), article number: e2742. (10.1002/hup.2742)

James, E., Keppler, J., Robertshaw, T. L. and Sessa, B. 2022. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Human Psychopharmacology: Clinical and Experimental 37(3), article number: e2835. (10.1002/hup.2835)
James, E., Robertshaw, T. L., Hoskins, M. and Sessa, B. 2020. Psilocybin occasioned mystical‐type experiences. Human Psychopharmacology: Clinical and Experimental 35(5), article number: e2742. (10.1002/hup.2742)
James, E., Robertshaw, T. L. and Westwell, A. D. 2019. Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances. Future Medicinal Chemistry 11(3) (10.4155/fmc-2018-0447)
James, E., Robertshaw, T., Chapman, F. M., Westwell, A. D. and Smith, A. P. 2019. Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs.. Drug Science, Policy and Law 5 (10.1177/2050324519876123)
James, E., Robertshaw, T., Westwell, A. and Smith, A. 2018. Pharmacies as potential providers of harm reduction services: A preliminary online survey. Drug Science, Policy and Law 4, pp. 1-14. (10.1177/2050324518767441)

Publication